EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events

Jiaqi He iD, Keting Liang, Ruijian Huang, Cunhua Su, Jiancheng Zhou iD, Lingli Wang, Jifang Zhou iD

Europace · 2025

DOI: 10.1093/europace/euaf268 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Europace, 2025. Verfasst von Jiaqi He und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of International Business, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing, Jiangsu 211198, China. Hauptthemen laut MEDLINE: Patient Readmission, Pacemaker, Artificial, Bradycardia, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

While transvenous pacemakers (TV-VVI) are standard for bradyarrhythmia, lead- and pocket-related complications remain concerns. Leadless pacemakers (LPMs) may reduce these risks. However, direct comparisons between LPMs and single-chamber TV pacemakers are limited. This study aimed to compare clinically meaningful outcomes between LPM and TV-VVI using real-world data. Methods and results Using the National Readmissions Database (NRD), we analysed demographics, readmission rates, and 30-day outcomes of patients aged ≥65 years who underwent LPM or TV-VVI implantation between 2016 and 2022. Admissions were identified via ICD-10 codes. Outcomes were assessed in the propensity score-matched population (10 594 patients per group) through multivariable logistic regression after 1:1 high-dimensional propensity score matching (caliper 0.1 SD) to adjust for confounding. Among 49 852 patients, 44.8% received LPM. Median age was 84 vs. 81 years in TV-VVI and LPM groups; 46.2% were female. TV-VVI patients had significantly higher rates of device-related complications [adjusted OR (aOR): 0.45, 95% CI (0.30–0.65), P < 0.001], device revision or replacement [aOR: 0.20, 95% CI (0.11–0.36), P < 0.001], implant-related complications [aOR: 0.58, 95% CI (0.34–0.97), P = 0.040]. Crude rates of arteriovenous fistula, pseudoaneurysm, and pericardial complications were higher in LPM, but adjusted differences were non-significant. Thirty-day readmission rates were similar between LPM and TV-VVI groups at 15.5% and 15.9%, respectively. Mortality and prolonged length of hospital stay also showed no significant differences.

Conclusion

Nationally representative data indicate that LPM implantation is associated with fewer device-related complications compared to TV-VVI, though further studies are needed to evaluate long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionPacemaker, ArtificialBradycardiaPostoperative ComplicationsCardiac Pacing, ArtificialHumansFemaleMaleAgedAged, 80 and overUnited StatesDatabases, FactualRisk FactorsTreatment OutcomeRetrospective StudiesEquipment Design

Stichwörter der Autor:innen

ComplicationsLeadless pacemakerMortalityOutcomesReadmissionTV-VVI

Autor:innen und Institutionen

  • School of International Business, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing, Jiangsu 211198, China.
  • Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Pharmacy, Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.
  • Department of Cardiovascular Medicine, The Affiliated Aoyang Hospital of Jiangsu University, No. 279 Jinggang Road, Zhangjiagang, Suzhou, Jiangsu 215600, China.

ORCID-Profile: Jiaqi He, Jiancheng Zhou, Jifang Zhou

Zitieren

APA

He, J., Liang, K., Huang, R., Su, C., Zhou, J., Wang, L., & Zhou, J. (2025). Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events. Europace. https://doi.org/10.1093/europace/euaf268

Vancouver

He J, Liang K, Huang R, Su C, Zhou J, Wang L, et al. Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events. Europace. 2025. doi:10.1093/europace/euaf268

BibTeX
@article{He2025,
  author = {He, Jiaqi and Liang, Keting and Huang, Ruijian and Su, Cunhua and Zhou, Jiancheng and Wang, Lingli and Zhou, Jifang},
  title = {Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf268}
}
Kostenlos starten →